wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41192354-1825B386-A18E-444C-880C-22B90F661741
Q41192354-1825B386-A18E-444C-880C-22B90F661741
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41192354-1825B386-A18E-444C-880C-22B90F661741
Combination of 5α-reductase inhibitor with combined androgen blockade (CAB) as a novel cytoreductive regimen before prostate brachytherapy: Ultra-CAB.
P2860
Q41192354-1825B386-A18E-444C-880C-22B90F661741
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41192354-1825B386-A18E-444C-880C-22B90F661741
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cc8dee275308984ccb4fa75a8e12ae8ee5c0977d
P2860
The risks and benefits of 5α-reductase inhibitors for prostate-cancer prevention.